Wellington Management Group’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
Other funds holding PETX
BC
EC
GAI
Wellington Management Group's PETX Position: Q1 2018 in Review
Wellington Management Group sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2018, closing a stake of 1,365,570 shares — an estimated $7.18M sold.
Wellington Management Group first reported a position in PETX in Q2 2013 and held it in 19 quarters. The position peaked at $65.4M in Q4 2014. 103 funds tracked by Wall St. Rank hold PETX as of Q1 2018.
- Wellington Management Group reported no remaining Aratana Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
- Wellington Management Group sold 1,365,570 Aratana Therapeutics, Inc. shares in Q1 2018, an estimated $7.18M.
- Wellington Management Group first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
- Wellington Management Group's Aratana Therapeutics, Inc. position peaked at $65.4M in Q4 2014.
- 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2018.
Based on Wellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.